ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,082, issued on March 31, was assigned to CHIA TAI TIANQING PHARMACEUTICAL GROUP Co. LTD. (Lianyungang, China).

"Fused tricyclic derivative and pharmaceutical application thereof" was invented by Peng Zhang (Shanghai), Yunfu Luo (Shanghai), Feng Gao (Shanghai) and Shuhui Chen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are a fused tricyclic derivative and a pharmaceutical application thereof. Specifically disclosed are a compound represented by formula (III) and a pharmaceutically acceptable salt thereof."

The patent was filed on Sept. 28, 2021, under Application No. 18/027,049.

*For further information, including images, ch...